The company Moderna, one of several testing COVID-19 vaccines, announced its own product appeared to be 94.5 per cent effective, according to preliminary data, the second company on track to seek permission within weeks for emergency use.
The announcement came as delays continued by the Trump administration in providing president-elect Biden with information on vaccine production.